Abstract: A motor vehicle has at least one drive unit for generating a drive torque, and has an accelerator pedal which is acted on with a restoring force and which can be adjusted by an actuating travel in order to predefine a setpoint torque. The motor vehicle also has a control device which actuates the drive unit on the basis of the setpoint torque. The control device additionally determines a presently available drive torque, and as a function of the presently available drive torque, varies the characteristic curve of the accelerator pedal, which expresses the restoring force versus the actuating travel of the accelerator pedal.

Abstract: A wheel suspension for motor vehicles includes at least one wheel guide element which is articulated both on an auxiliary frame that can be connected to the body of the motor vehicle and on a wheel carrier, a suspension and damping system as well as a steering system for the wheel. To achieve a universally applicable wheel suspension using identical parts, the auxiliary frame for each wheel suspension is designed as an independent modular frame, on which the a wheel guide element(s) is/are articulated, on which the suspension and damping system is supported, and on which at least one actuator is arranged directly or indirectly for actuating the suspension and damping system and/or the steering system and thus for setting predetermined wheel-specific wheel guidance and/or steering parameters.

Abstract: Vaccine comprising a peptide bound to a pharmaceutically acceptable carrier, said peptide having the amino acid sequence (Formula?I) (SEQ?ID?NO:?1) (X1)m(X2)n(X3)oX4X5HPX6, for treating and/or preventing a physical disorder associated with the renin-activated angiotensin system, wherein X1 is G or D, X2 is A, P, M, G, or R, X3 is G, A, H, or V, X4 is S, A, D, or Y, X5 is A, D, H, S, N, or I, X6 is A, L or F, wherein m, n and o are independently 0 or 1 under the premise that when o is 0 m and n are 0 and when n is 0 m is 0, and wherein the peptide is not DRVYIHPF (SEQ ID NO:4).

Abstract: A wheel suspension for motor vehicles includes at least one upper control arm, in particular an upper transverse control arm, and at least one lower control arm, in particular a lower transverse control arm, which are hinged on the body of the motor vehicle suspension on the one hand, and on the other hand are connected to a wheel carrier, thus forming a preferred, substantially vertical steering axle. At least one suspension spring and at least one shock absorber are provided. The at least one suspension spring and/or the at least one shock absorber are designed to be rotatable.

Abstract: A mobile apparatus and process for adequately irrigating soil, wherein the apparatus has an irrigation unit for irrigating soil and a mobile microwave measurement unit for determining the water content of the soil along a measurement path. A control unit is used to irrigate the soil along the measurement path depending on the measured water content. The apparatus preferably also has a water tank and leaves an area of soil to be irrigated autonomously.

Abstract: The invention relates to an arrangement of a stabilizer (26), which is configured in two parts, on a wheel suspension for a motor vehicle, comprising torsion bars (26b) which are separated from each other and are each articulated on wheel suspension elements (16) by means of an output lever (26a) and can be co-rotated in the same or opposite direction by means of associated actuating devices (30), wherein each torsion bar (26b) is extended with a hollow shaft (26e) which encompasses the torsion bar (26b) in order to increase the effective torsion length, the output lever (26a) being formed on the hollow shaft. According to the invention, the torsion bar (26b) is mounted in a fixed bearing (59) in the actuating device (30) and in an axial loose bearing (26d) in the hollow shaft (26e).

Abstract: The invention relates to an arrangement of a stabilizer (44), which is configured in two parts, on a wheel suspension for a motor vehicle, characterized in that the stabilizer parts (43) thereof can be rotated relative to one another in the same or opposite direction by means of an associated motor/gear unit (46). Each stabilizer part (43) comprises a hollow-cylindrical outer torsion bar (49) whose end on the gear side (45) is connected to a gear output (50a) and whose end distal from the gear is connected for drive purposes to an inner torsion bar (47) which is guided through the hollow-cylindrical outer torsion bar (49) and out of the end (45) on the gear side of the hollow-cylindrical outer torsion bar. The inner torsion bar (47) is directly or indirectly connected to an output lever (41) which is articulated on a wheel suspension element (16).

Abstract: The present invention relates to the use of compounds for producing a medicament for preventing and/or treating atherosclerosis, atherosclerosis risk diseases and atherosclerosis sequelae.

Abstract: A method for the automatic irrigation of plants, wherein the temporal progression of soil moisture is determined from measured soil moisture values, and said progression is used for the calculation of an optimized irrigation time duration, such that both water excess in the soil and soil drying are avoided as much as possible. Preferably, the time duration of irrigation is constantly evaluated and optimized using comparisons of measured values with prespecified moisture- and dryness threshold values (GWmoist, GWdry), and automatically adjusted to changing environmental conditions and/or plant requirements.

Abstract: The invention relates to the use of a compound comprising the following amino acid sequence X1X2X3X4X5X6X7, wherein X1 is an amino acid, except of C, X2 is an amino acid, except of C, X3 is an amino acid, except of C, X4 is an amino acid, except of C, X5 is an amino acid, except of C, X6 is not present or any amino acid, X7 is not present or any amino acid, and wherein X1X2X3X4X5X6 is not DAEFRH, said compound having a binding capacity to an antibody being specific for the natural N-terminal A?42 sequence DAEFRH, and 5-mers thereof having a binding capacity to said antibody being specific for the natural N-terminal A?42 sequence DAEFRH, for the preparation of a vaccine for Alzheimer's disease.

Abstract: The invention relates to a method and device for determining the water content of a medium, particularly of soils and the like, in which a probe or sensor (8) located in the medium is heated. A temporary change in temperature is effected by dissipating the thermal energy through the moisture in the area surrounding the probe, this change in temperature being used for determining the moisture content of the medium. An intermediate layer (13) is placed between the probe and the surrounding medium and is absorbent and mechanically deformable for mechanically coupling the probe to the surrounding medium and for decoupling the probe and the surrounding medium thereby enabling a precise measurement of moisture content to ensue while being subjected to the least possible thermal influence by the largely undetermined surrounding medium.

Abstract: The invention relates to a method for preventing or treating Alzheimer's disease (AE). According to said method, a means for inducing a sequestration of amyloid ? (A?) into a plasma is administered to a person, and the person is treated by means of an apheresis device comprising a fixed carrier that can come into contact with the blood or plasma flow and comprises a receptor binding an amyloid-?-precurser-protein (APP), the APP being removed from the blood of the person by means of the apheresis device. The invention also relates to a set for carrying out said method.

Abstract: The invention relates to an apharesis device for use in the treatment of Alzheimer patients. Said device comprises a solid support with which a flow of blood or plasma can be contacted.

Abstract: The invention relates to a method for treating Alzheimer's disease by inducing sequestration of amyloid ? into a plasma with a A?-mimotope peptide, and treatment with an apheresis device such that a fixed carrier can come into contact with the blood or plasma flow and includes a receptor that binds to an amyloid-? precursor-protein (APP), the APP being removed from the blood with the apheresis device.

Abstract: The invention relates to an apheresis device for use in the treatment of Alzheimer patients. Said device comprises a solid support with which a flow of blood or plasma can be contacted.

Abstract: The present invention relates to a compound comprising a peptide for treating, preventing and/or ameliorating motor symptoms of Parkinson's disease, said peptide having a binding capacity to an antibody which is specific for an epitope of the amyloid-beta-peptide (A?).

Abstract: Described is an immunostimulatory oligodeoxynucleic acid molecule (ODN) having the structure according to formula (I), wherein any X is O or S, any NMP is a 2? deoxynucleoside monophosphate or monothiophosphate, selected from the group consisting of deoxyadenosine-, deoxyguanosine-, deoxyinosine-, deoxycytosine-, deoxyuridine-, deoxythymidine-, 2-methyl-deoxyinosine-, 5-methyl-deoxycytosine-, deoxypseudouridine-, deoxyribosepurine-, 2-amino-deoxyribosepurine-, -6-S-deoxyguanine-, 2-dimethyl-deoxyguanosine- or N-isopentenyl-deoxyadenosine-monophosphate or -monothiophosphate, NUC is a 2? deoxynucleoside, selected from the group consisting of deoxyadenosine-, deoxyguanosine-, deoxyinosine-, deoxycytosine-, deoxyuridine-, deoxythymidine-, 2-methyl-deoxyinosine-, 5-methyl-deoxycytosine-, deoxypseudouridine-, deoxyribosepurine-, 2-amino-deoxyribosepurine-, 6-S-deoxyguanine-, 2-dimethyl-deoxyguanosine- or N-isopentenyl-deoxyadenosine, any X is O or S, a and b integers from 0 to 100 with the proviso that a+b is betwe

Abstract: The invention relates to an independent wheel suspension for the rear wheels of motor vehicles, having a wheel support which is hinge-connected to at least one upper and one lower control arm, the lower control arm being connected by way of two more or less horizontal arm bearings forming pivot axes on the body of the motor vehicle and on the wheel support and a guide arm of the wheel support to another bearing, and also having a bearing spring resting on the wheel support and a more or less vertically oriented telescopic shock absorber. For the creation of a structurally and elastokinematically favorable wheel suspension it is proposed, as viewed from above, that the other guide rod is mounted more or less in the lower guide rod plane and diagonally forward from the exterior toward the interior, in such a way that the intersection of imaginary extensions of the other guide rod and the rear bearing points of the lower guide rod is positioned beyond the extended wheel center axis.

Abstract: The polymer compound contains a polymer matrix and a filler embedded in the matrix. The filler comprises two filler components with nonlinear current-voltage characteristics deviating from one another. By selection of suitable amounts of these filler components, a polymer compound with a predetermined nonlinear current-voltage characteristic deviating from these two characteristics can be formed in this way.

Abstract: The invention discloses polypeptides encoded by an alternative reading frame of a pathogenic virus, which polypeptides—start with a methionine amino acid residue,—comprise an antigenic determinant and—comprise more than 7 amino acid residues and fragments of said polypeptides comprising more than 7 amino acids.